Avenue Therapeutics Inc (ATXI)
3.44
-0.17
(-4.71%)
USD |
NASDAQ |
May 31, 16:00
3.44
0.00 (0.00%)
After-Hours: 20:00
Avenue Therapeutics Enterprise Value: -0.895M for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | -0.895M |
| May 30, 2024 | -0.735M |
| May 29, 2024 | -0.6221M |
| May 28, 2024 | -0.6409M |
| May 24, 2024 | -0.7256M |
| May 23, 2024 | -0.7256M |
| May 22, 2024 | -0.6409M |
| May 21, 2024 | -0.5562M |
| May 20, 2024 | -0.5468M |
| May 17, 2024 | -0.6221M |
| May 16, 2024 | -0.7162M |
| May 15, 2024 | -0.6974M |
| May 14, 2024 | -0.5186M |
| May 13, 2024 | -0.4151M |
| May 10, 2024 | -0.3688M |
| May 09, 2024 | -0.2277M |
| May 08, 2024 | 0.0075M |
| May 07, 2024 | -0.8988M |
| May 06, 2024 | -0.6602M |
| May 03, 2024 | -0.4524M |
| May 02, 2024 | -0.4601M |
| May 01, 2024 | -1.297M |
| April 30, 2024 | -1.148M |
| April 29, 2024 | -1.468M |
| April 26, 2024 | -0.4734M |
| Date | Value |
|---|---|
| April 25, 2024 | 1.094M |
| April 24, 2024 | 0.0797M |
| April 23, 2024 | 1.853M |
| April 22, 2024 | 1.679M |
| April 19, 2024 | 1.674M |
| April 18, 2024 | 1.826M |
| April 17, 2024 | 1.848M |
| April 16, 2024 | 1.689M |
| April 15, 2024 | 1.401M |
| April 12, 2024 | 1.866M |
| April 11, 2024 | 2.118M |
| April 10, 2024 | 2.490M |
| April 09, 2024 | 2.370M |
| April 08, 2024 | 2.663M |
| April 05, 2024 | 2.455M |
| April 04, 2024 | 2.375M |
| April 03, 2024 | 2.464M |
| April 02, 2024 | 2.508M |
| April 01, 2024 | 2.512M |
| March 28, 2024 | 3.817M |
| March 27, 2024 | 4.043M |
| March 26, 2024 | 3.972M |
| March 25, 2024 | 4.149M |
| March 22, 2024 | 3.981M |
| March 21, 2024 | 4.295M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.291M
Minimum
Apr 24 2023
195.54M
Maximum
Sep 14 2020
50.58M
Average
21.21M
Median
Oct 06 2021
Enterprise Value Benchmarks
| Fortress Biotech Inc | -9.667M |
| SINTX Technologies Inc | -1.081M |
| Deciphera Pharmaceuticals Inc | 1.936B |
| Flora Growth Corp | 13.89M |
| NovaBay Pharmaceuticals Inc | 4.387M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -4.34M |
| Total Expenses (Quarterly) | 3.708M |
| EPS Diluted (Quarterly) | -1155.00 |
| Earnings Yield | -34.52K% |